EKF Diagnostics Investor Announcements
EKF Diagnostics Holdings plc is an in-vitro diagnostics (IVD) business. The Company is engaged in the designing, development, manufacture and selling of diagnostic analyzers, reagents and ancillary products. This activity takes place across several geographical locations which include the United Kingdom, United States of America, Germany, Poland and Russia.
EKF announces that it has recently won two new tenders for its Hemo Control point-of-care hemoglobin analyser.
Public Opening Position Disclosure by a Party to an Offer. Rules 8.1 and 8.2 of the Takeover Code.
Non-binding proposal for Point of Care division withdrawn.
EKF Diagnostics Holdings plc has received a preliminary approach regarding a possible acquisition.
Proposal received to offer $115-$125m in cash for POC business.
EKF Diagnostics Holdings plc announced on 2 April 2015 that the Board of Directors had initiated a strategic review headed by a Committee of the Non-Executive Directors of EKF.
EKF Diagnostics Holdings plc announces conclusion of Strategic Review.